Crohn’s disease is an inflammatory bowel disease linked to an imbalance in the gut microbiome. Now, researchers at McMaster University have found in mice a way to target and 'turn off' only the bad gut bacteria using specially trained, precision viruses. This breakthrough paves the way for treatments tailored to each patient.
Struggling with constipation? Two bacteria in your gut microbiota may be to blame
8 Jul 2026by Cristina Sáez
A new study identifies two common gut microbes that work together to degrade mucin, a key lubricant for stool movement. This mechanism may explain why many treatments fail to provide lasting relief. The findings could pave the way for personalized therapies and new diagnostic biomarkers.
What do the soil under our feet, the pets in our homes, and the microbes in fermented foods all have in common? They are all part of the same vast microbial web, and they all help shape your gut.
Stay tuned to our latest news
Food 4 Gut Health news
One in four adults experience digestive symptoms that impact quality of life
15 Jun 2026by Andreu Prados
Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.
Dietary fiber is often seen as essential for gut health. However, is it always beneficial? New research challenges this idea, highlighting that not all fibers act the same and that context, type, and dose matter.
Research & Practice news
Parasites, often seen as villains, may help shape gut and metabolic health
21 Sep 2026by Giovana Martucelli
Blastocystis has long been viewed mainly as a marker of parasitic infection. Emerging research reviewed here suggests that its presence is not necessarily linked to disease, but may instead reflect greater microbial diversity and metabolic health in certain contexts.
Alterations in the composition and function of the gut microbiota are recognized as key contributors to the pathophysiology of IBS. In this interview with Prof. Carmelo Scarpignato, we discuss the knowns and unknowns of gut microbiota in IBS, the four levels of gut microbiota manipulation, and examples of microbiota-targeted approaches available for the clinician.
The fifth edition of IBS Days delved into the latest developments in IBS research and clinical management. This article aims to explore causes that can be misdiagnosed as IBS and non-pharmacological strategies targeting gut barrier and gut microbiome dysfunction.
